chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for Covid after getting the vaccine; tested positive for Covid after getting the vaccine; This is a spontaneous report from a contactable consumer (friend) reported for a female patient. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration on an unspecified date (Lot number and expiry date was not reported) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 13Jul2021, the patient tested positive for COVID after getting the vaccine. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on 13Jul2021. The event outcome was unknown.    Information on the lot/batch number has been requested.
Weight before vaccine was 120 pounds, weight as of now is 92 pounds.; throwing up on and off, vomiting episodes were lasting 1.5 weeks on average; started losing hair, really big patches of hair; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 20-year-old female patient received BNT162b2 (BNT162B2), on 13May2021 at 14:00 as dose 2, single (Lot number: EW0167) at the age of 20 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EW0172, Anatomical location: Arm left, Administration time: 14:00), administration date: 22Apr2021, when the patient was 20-year-old, for Covid-19 Immunization. The following information was reported: ALOPECIA (non-serious) with onset May2021, outcome "recovering", described as "started losing hair, really big patches of hair"; VOMITING (non-serious) with onset Aug2021, outcome "not recovered", described as "throwing up on and off, vomiting episodes were lasting 1.5 weeks on average"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "Weight before vaccine was 120 pounds, weight as of now is 92 pounds.". The events "throwing up on and off, vomiting episodes were lasting 1.5 weeks on average" required emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that, Caller was calling about the Pfizer vaccine 1st and 2nd doses, clarified caller was calling about the Pfizer COVID-19 vaccine. Had been experiencing bad side effects after taking the 2nd dose of the vaccine. Calling to report those side effects. Caller started losing hair, really big patches of hair. Throwing up on and off, vomiting episodes were lasting 1.5 weeks on average. 1st episode of vomiting was Aug2021. Patient weight before vaccine was 120 pounds, weight as of now is 92 pounds. The Stop date of adverse event started losing hair, really big patches of hair was reported as right now hair is growing back. Outcome of event vomiting worsened because caller would have a vomiting episode for an average of 1.5 weeks and then would get the next vomiting episode 2-3 months later, but now the vomiting episodes are happening every month. Vomiting episodes had occurred once a month in May2022, Jun2022, and Jul2022. Had gone to the emergency room, was seen in the emergency room and had a check up at emergency room. Confirmed caller was not admitted to the hospital. Went to the emergency room for vomiting, has gone to the emergency room 4 times total for the vomiting. Most recent emergency room visit was on Tuesday, 12Jul2022. Prior Vaccinations (within 4 weeks), the patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient had no AE prior vaccinations. The patient used to be really healthy before getting the vaccine. The patient had no relevant tests. The patient did not receive additional vaccines on Same Date with the Pfizer vaccine.
This spontaneous report was received from the patient's husband referring to his wife, a female patient of unknown age. The patient's pertinent medical history, drug reactions and allergies were not reported. Information regarding concomitant therapies was not provided. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, frequency, route of administration, lot number and expiration date were not provided) for prophylaxis. The patient's husband stated that the patient reported having unspecified adverse effects (adverse event) after receiving the PNEUMOVAX 23. At the reporting time, the outcome of adverse event was not reported. The reporter did not assess the causality between the adverse event and PNEUMOVAX 23.
Injection site pain; swelling; Body aches; Fever; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 05May2021 at 10:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took sulfa. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 12:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021 at 20:00, the patient experienced injection site pain, swelling, body aches, fever, nausea and fatigue. The clinical outcome of the events injection site pain, swelling, body aches, fever, nausea and fatigue were not resolved.  No follow-up attempts are needed. No further information is expected.
sleep most of the day after vaccine and all night; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleep most of the day after vaccine and all night), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a 73-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. 3030371) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Sep-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 21-Sep-2023, the patient experienced SOMNOLENCE (sleep most of the day after vaccine and all night), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). On 22-Sep-2023, SOMNOLENCE (sleep most of the day after vaccine and all night), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use), the reporter did not provide any causality assessments.   No concomitant medications were reported. These adverse reactions have been same after each shot. It was unknown if the patient experienced any additional symptoms/events. No treatment medications were provided.
Joint pain, chest pain, headaches, mouth sores, irritated eyes, evolved to passing out, fingers turning blue, having new symptoms regularly.
Slight dizziness 30 minutes after vaccination otherwise fine, left work and still is experiencing dizziness as of 10:00 PM 4/12/16. No other symptoms.
Patient was given COVID Pfizer vaccine approximately 13:30. Less than 1 minute later patient went out for a few seconds and was convulsing.  Patient was very clammy and sweating.  I requested help from RN and we called Dr, our clinical medical director via facetime.  He stated he couldn't move his hands and didn't know what was happening.  He then stated he was have trouble breathing.  Dr  instructed to administer Epi Pen and call 911.  Epi pen was administered at 13:36 to left VL without any complications. EMS arrived at 1341 and took over patient care.
Patient felt very dizzy with visual disturbance and felt like eyes were dilated. Patient felt slightly nauseous and vomited a small amount.
Severe Chills, 6 hours Fever of 102,  gradually decreasing, 48 hours Headache, several hours Body Pain , 48 hours
Sore arm; Achy body; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (Achy body) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), MYALGIA (Achy body) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), MYALGIA (Achy body) and HEADACHE (Headache) outcome was unknown. Not Provided          Concomitant medication use was unknown Treatment information was unknown. Action taken with mRNA-1273 in response to the event was not applicable.     This case was linked to MOD-2021-090536, MOD-2021-090511 (Patient Link).   Reporter did not allow further contact
Patient developed this at 2 yrs. of age.  Patient can get around with help of braces.
Redness, pruritis, slight cellulitis 18cm x 16cm (L) arm.
On 1-9-09 patient had a seizure at 7:00 pm. No fever was noted by his mom.  Diastat 2.5 mg was given rectally times two doses and patient was fully recovered by 8:00 pm.  On 1-11-09 at 1:30 am patient had a fever of 102.7 and was having tremors. His mom gave him 3/4 tsp. of motrin and tylenol.  At 2:00 am he had a seizure. Diastat was given times one dose. Patient fully recovered from seizure by 11:00 am that morning.
RUSH IN VACCINATION AREA, DEVELOPING AS A CHEST RUSH,  BODY HEAT FLUSH.
still having problems in his lower back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "still having problems in his lower back".  Additional Information: Caller stated that "I was in there last week" and the therapist shared with caller "one gentleman was still having problems in his lower back" and this particular gentleman got the "shot about the same time as I did" and that the "others recouped.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (22Dec2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
This spontaneous report was received from a healthcare professional who reported that in January 2014, 21 improperly stored doses of ROTATEQ, (oral, dose, batch and lot number not reported) were administered by a clinic to an unspecified number of patients (age and gender were not reported). No adverse effects were reported. This is one of several reports from the same source. Follow up information has been received on 17-MAR-2014. All telephone attempts to obtain follow-up information had been unsuccessful. Follow up information has been received on 22-SEP-2014. Demographic details for each patient were provided. This report referred to a  4-months old male patient, with no known drug allergies and no illness at time of vaccination. The patient was vaccinated with the second dose of ROTATEQ (oral, batch/lot # J001254, expiration date 19-SEP-2014), on 10-FEB-2014 at 11:30 AM. It was reported that this dose was spoiled since the refrigerator was too cold (onset of event also reported as 27-FEB-2014 at 10:00 AM). The patient was revaccinated on 07-APR-2014 with no change. No adverse event was reported for the patient. This is one of several reports from the same source. Additional information is not expected since all follow ups requested to complete the case were received.
Per wife, patient received Pfizer COVID vaccine at the clinic on 3/1/21 and 3/22/21. On 1/4/22, patient tested positive for COVID and was admitted to our inpatient unit with COVID-19 pneumonia and acute hypoxic respiratory failure. As of today (/1/6/22), patient is still admitted in our med/surg unit.
re/mom [lobby]: [7/24] TRUMENBA given---[7/25] redness/swelling left deltoid, applied ice pack---[7/28] erythematous pruritic papular lesions upper chest and upper back---[7/30] rash face....denies applying any new cosmetic/lotion, denies eating new foods. Start BENADRYL tablet, 50 mg, 1 tab q 6-8 hours x 3d then prn rash, PO, 30 days, 30, Refills 0. Start hydrocortisone topical ointment, 1%, 1 app, applied topically, 3 times a day, 7 days, 30 Gram, Refills 0. Notes: will report to VARS [with photos]. advised not to have TRUMENBA #2.
Information has been received from a 44 year old female consumer who in approx. 1968 at the age of 15, 1990 and May, 1998 was vaccinated with the 1st, 2nd and 3rd dose of pneumococcal vaccine 23 polyvalent respectively. Since May, the pt has experienced "jerking in my body", couldn't sleep and tissue degeneration in feet, arms and palms of hands. The reporter stated "my body used to be firm and now everything is soft". She also stated that "I can't even walk far without feeling pain" and "it is like my aging process is speeding up". The pt stated that the symptoms have worsened over the years. The pt has spoken to her physician. Follow-up information received on 10/5/00, from the consumer stated that her "auto immune system has gone in overdrive". She stated that her physician reported her subcutaneous tissue is breaking down. The pt was inquiring about the ingredients in the pneumococcal vaccine 23 polyvalent. Upon medical review, the pt's auto immune system overdrive was considered to be an "other medical event". No further information is available.  Follow up on 03/28/2001: "Adverse event time and Lot # for vaccine 1 is not provided."  Follow up on 06/29/2001: "Lot # for vaccine 1 is not provided."
Discomfort; Leg swells twice the size; This spontaneous case was received on 02-Sep-2020, from other health professional via agency (reference number: SEQW20-01197) and concerned a male patient of unspecified age. At the time of this report the patient was a 3-year-old.   The patient's concurrent condition included anaphylaxis to eggs. The patient's concomitant medications were not reported.   On an unknown date, the patient was vaccinated with INN Seasonal flu vaccine (influenza virus vaccine polyvalent, dose, route of administration and anatomical location: not reported) for influenza prophylaxis.   The batch number was not reported.  On an unspecified date, an unknown amount of time after receiving INN Seasonal flu vaccine, the patient's leg swelled twice the size and the patient experienced discomfort.   On an unspecified date, reported as one to two weeks after the onset, the patient recovered from the events.  The reporter assessed the events of 'unilateral leg swelling' and discomfort to be related to INN Seasonal flu vaccine.  The reporter assessed the events as non-serious.  Company comment:The patient developed discomfort and peripheral swelling on an unknown date and unknown amount of time after vaccination with the suspect product, INN Flu Vaccine Seasonal. Chronology is unclear. No information regarding concomitant medication was provided. Based on this information, causal relationship for both events is assessed as unassessable.; Sender's Comments: The patient developed discomfort and peripheral swelling on an unknown date and unknown amount of time after vaccination with the suspect product, INN Flu Vaccine Seasonal. Chronology is unclear. No information regarding concomitant medication was provided. Based on this information, causal relationship for both events is assessed as unassessable.
Since 1 week after the vaccine she has been experiencing intermittent chills without fever, pruritis from the waist up starting 1/17/21 and changes in her taste with no loss of taste or smell.
Fever; malaise; muscle fatigue; muscle fatigue and pain; joint pain; swollen lymph nodes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 28 year-old male patient received bnt162b2 (COMIRNATY, solution for injection), administered in arm left, administration date 05Nov2021 (Lot number: EW0217) at the age of 28 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medication(s) included: ZYRTEC ALLERGY; LEXAPRO. Vaccination history included: Comirnaty (Product: COVID 19, Brand: Comirnaty, Dose Number: 2, Batch/Lot No: EN 5318, Location of injection: Left Arm), administration date: 17Feb2021, when the patient was 28 years old, for COVID-19 Immunization; Comirnaty (Product: COVID 19, Brand: Comirnaty, Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Left Arm), administration date: 27Jan2021, when the patient was 27 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious) with onset 06Nov2021, outcome "recovering", described as "Fever"; MALAISE (non-serious) with onset 06Nov2021, outcome "recovering", described as "malaise"; MUSCLE FATIGUE (non-serious) with onset 06Nov2021, outcome "recovering", described as "muscle fatigue"; MYALGIA (non-serious) with onset 06Nov2021, outcome "recovering", described as "muscle fatigue and pain"; ARTHRALGIA (non-serious) with onset 06Nov2021, outcome "recovering", described as "joint pain"; LYMPHADENOPATHY (non-serious) with onset 06Nov2021, outcome "recovering", described as "swollen lymph nodes". Therapeutic measures were taken as a result of pyrexia.  Additional information: patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. As a treatment patient took ibuprofen for the fever. Prior to vaccination, the patient was not diagnosed with COVID-19.  No follow-up attempts are possible. No further information is expected.
Patient developed a "metalic taste in mouth." Also complained of feeling tired, initially with headache and burning on the inside of body. Also complained of itching in back of throat and roof of mouth. Symptoms began approximately 5 minutes after injection given.
Itching; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient received bnt162b2 (COMIRNATY), administered in arm right, administration date 13Oct2021 (Lot number: 30155BA) at the age of 32 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Lot Number: FF2587, Anatomical Location: Arm Right), administration date: 21Sep2021, when the patient was 32 years old, for COVID-19 immunisation. The following information was reported: PRURITUS (non-serious) with onset 13Oct2021, outcome "not recovered", described as "Itching".  Additional information: It was reported that the patient had not taken prior vaccinations within 4 weeks. The time the vaccination was given was between 10:30-10:45. She noticed that within the last 10 minutes the event occurred. The reporter confirmed that she started no new medications within the last 2 weeks. The reporter stated that she had been on the same medicine for a while. She referred caller back to her healthcare professional and or vaccine facility for any treatment recommendations or medical advice.  Follow-up attempts are completed. No further information is expected.
Adverse Event:  "Vaccine Arm" ... red, swollen, itchy upper arm, near injection site.
Pt. reports severe headache, spinal pain, fever, and sensitivity to light. Pt. reports she has Epstein-Barr but did not notify clinician at time vaccines were given. Advised pt. go immediately to ER.
When parents returned with infant for 4 mo. immunizations, reported that he and his twin became ill with fever, vomiting and diarrhea within 24 hrs of 2 mo immunizations. Fever of 103 progressed to vomiting/diarrhea. Hospitalized with IV fld. therapy.
Per triage nurse, " Pt feeling dizzy and began to cry stated she did not want to pass out, was hyperventilating, given fruit snacks. Pt was helped to the ground, legs were elevated and vitals were taken. Vitals all WNL, oxygen via nasal canula at 2L was applied. Pt was able to answer basic questions, would take a while to answer. Dr. stated that patients vitals were fine and that nursing should keep patient in a calm environment and sit her up. Patient was given juice and fruit snacks, nurse and medic  were present on site. Patient unable to tolerate sitting up, medic and nurse transferred patient over to gurney and was taken to ambulance past border."
Patient received the incorrect vaccine.  She received Pfizer Covid-19 vaccine intended for 5-12 yr old patients.  I contacted the patient and she understands that she will need revaccinated with the correct vaccine.  No adverse effects were reported by patient.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 24-DEC-2012, the patient was inoculated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. In 2015, the patient was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
The evening of the vaccine she could not move her left arm at all. She is still having limited movement and pain. She can not lift her arm above her head to remove her shirt without significant pain.
Tdap administered on 4/29/15 and on 4/30/15 left arm began to swell with redness noted to upper arm. Itching also noted to upper region. Patient took ibuprofen at home. Seen in clinic on 5/5/15 and prescribed CLARITIN, warm compresses and MEDROL dose pak.